Stockopedia alternatives
Stockopedia alternatives
that add US and Canadian stocks
to European screening.
Stockopedia EU costs €60/month and covers UK equities well — but continental European microcaps have gaps, and US and Canadian equities are excluded entirely. Adding US access brings the price to €80/month. Below are the real alternatives, compared honestly.
Updated October 2026 · 5 alternatives reviewed
What you get over Stockopedia
US + Canadian stocks
Stockopedia EU excludes US and Canadian equities entirely. ScreenerHero covers the full US market and TSX/TSXV — all in the same screener.
European microcap depth
Stockopedia has gaps in continental European microcaps and illiquid names. ScreenerHero covers all European exchanges including small and microcap names across BME, XETRA, Euronext, and Borsa Italiana.
Modern, faster UI
Stockopedia leans on card-based layouts and editorial commentary around the data. ScreenerHero is desktop-first and built for speed — filters apply instantly and results are dense, sortable tables.
No monthly fee
Stockopedia EU is €60/mo. Stockopedia US+EU is €80/mo. The ScreenerHero paid plan is a one-time Lifetime payment for US + Canada + Europe + Australia — no monthly fee, with broader coverage.
What to look for in a Stockopedia alternative
Geographic coverage
Does it cover US, Canada, and continental Europe — not just UK equities? And does it include microcaps, or only the large caps?
Filter flexibility
Stockopedia centers on StockRanks composites. Do you need those scores, or would raw filter sliders (P/E, ROE, EV/EBITDA) serve you better?
Price vs coverage ratio
At €60–80/month, Stockopedia is expensive relative to coverage. What does the alternative include for the money?
European microcap reliability
Is fundamental data populated for small and illiquid European names? Missing data is normal — but a good tool shows it rather than hiding it.
UX speed
Stockopedia is not a fast interface. If filter speed and dense output matter to your workflow, check whether the alternative prioritizes this.
The 5 best Stockopedia alternatives (2026)
ScreenerHero
US + Canada + Europe + Australia. More coverage. No monthly fee.
ScreenerHero covers US, Canada, Europe & Australia — including microcaps and illiquid names — with a one-time paid plan. Stockopedia EU is €60/month with no US and no Canada. Stockopedia US+EU is €80/month. ScreenerHero has broader geographic coverage, a faster interface, no monthly fee, and a free core screener that requires no account.
Markets
US, Canada, Australia, BME, Euronext Paris, XETRA, Borsa Italiana — all European exchanges
Screener filters
P/E, P/B, ROE, EV/EBITDA, margins, beta, momentum, dividend yield
UI style
Desktop-first, data-dense, filter-driven
Heatmap
Yes
TIKR
Global coverage at an aggressive price — microcap EU depth is limited
Broad global coverage with a loyal user base. TIKR Plus is priced aggressively at $25/month. European microcap and illiquid stock coverage is a known weak point. Good for large-cap global research; less reliable for European small caps.
Markets
100k+ stocks, 92 countries
Screener filters
Fundamentals, historical data, transcripts on higher plans
UI style
Data-focused, less dense than Stockopedia
Heatmap
No
TradingView
Global charting platform — screener is secondary
World-class charting with European coverage. The screener is not the core product — fundamental depth for European small caps is inconsistent, and filter combinations are restricted on lower plans. A reasonable choice if charting drives your workflow.
Markets
Global, including Europe
Screener filters
Technical-first; fundamental filters gated by plan
UI style
Chart-centric, screener is a secondary feature
Heatmap
Yes
MarketScreener
Deep European data, news-first product, dated UX
One of the broadest European fundamental databases available. The product prioritizes analyst consensus and news — screening is secondary. The UX is old and slow. Useful as a European data reference but not a Stockopedia replacement for research workflows.
Markets
Europe and global
Screener filters
Fundamentals, analyst estimates, 300–600 filters
UI style
Table-based, built around news and analyst reports
Heatmap
No
Simply Wall St
Visual, beginner-friendly — not a filter-driven screener
Good for understanding a single company visually. Not a screener in the systematic sense — there are no dense filter combinations or sortable results tables. Useful for beginners exploring individual names, not for multi-market quantitative screening.
Markets
Global, including Europe
Screener filters
Limited — snowflake visual, no dense filter UI
UI style
Infographic cards, designed for individual stock browsing
Heatmap
No
Quick comparison
| ScreenerHero | TIKR | TradingView | MarketScreener | Simply Wall St | |
|---|---|---|---|---|---|
| US coverage | |||||
| Canadian coverage | |||||
| European coverage | |||||
| Microcap EU coverage | |||||
| Dense screener UI | |||||
| Heatmap | |||||
| Free core features | |||||
| No account required | |||||
| Paid plan (from) | 97€ once | $10/mo | $15/mo | $30/mo | $10/mo |
Recommendation by use case
You invest across US, Canadian, European & Australian equities including microcaps
ScreenerHero — covers everything Stockopedia covers, plus US and Canada, with a one-time payment instead of a monthly fee.
You need composite QVM scores rather than raw filter sliders
Stockopedia — StockRanks is well-regarded for UK equities; accept the price and coverage limits.
You want broad global coverage at a low price point
TIKR Plus — $25/mo, wide coverage, accept European microcap gaps.
You want the deepest European news and analyst consensus data
MarketScreener — best EU database, but built for research not fast screening.
You prefer visual stock stories over systematic screening
Simply Wall St — good for browsing individual names, not systematic multi-market screening.
Score-first vs filter-first
Stockopedia is score-first. StockRanks distil quality, value and momentum into pre-computed composites: you screen for high-ranking stocks rather than building your own filter combinations. That suits investors who trust the composite method and want to skip the filter-building.
ScreenerHero is filter-first. You set raw criteria (P/E below X, ROE above Y, margin above Z) and the screener returns everything that passes. That suits investors with a specific thesis to test rather than a scoring system to follow. Neither is better in absolute terms; they reflect different investment philosophies.
Stockopedia does not have a free tier: there is a trial, but ongoing access needs a subscription. ScreenerHero's core screener is free and needs no account.
When Stockopedia is still the right choice
If StockRanks is central to your process. The QVM composite is genuinely distinctive; if high-ranking StockRanks candidates are your primary signal, there is no equivalent elsewhere at this price.
If you focus mainly on UK stocks. Its deepest and most reliable data is on UK-listed companies, so for a universe of LSE Main Market and AIM names the data advantage is real.
If you rely on its editorial content. The StockReports and the commentary around individual companies are a genuine part of the product.
Frequently asked questions
What is the cheapest Stockopedia alternative with European coverage?
ScreenerHero covers the European exchanges, including growth markets where Stockopedia has gaps, plus US and Canadian stocks. Its core screener is free and its paid plan is a one-time payment, where Stockopedia is a subscription (US + Europe plan, €80 a month; €64 a month if billed yearly; checked 13 Oct 2026).
Does Stockopedia cover European microcaps?
It covers UK small and microcaps well. Continental European microcaps, particularly on Euronext Growth Paris, Nasdaq First North, Euronext Growth Milan and NewConnect, are covered inconsistently, which is a real limitation for investors focused on smaller continental companies.
Which Stockopedia alternative has the best European coverage?
ScreenerHero has the broadest European coverage in this comparison, including the growth markets Stockopedia misses. MarketScreener covers continental Europe well, with a slower, news-first interface.
Is Stockopedia worth €60–80 a month?
For UK-focused value investors who actively use StockRanks, it buys genuine functionality. For continental European investors, or investors who need US coverage at a reasonable total price, the case is weaker: alternatives cover more markets with a one-time paid plan.
Can I migrate from Stockopedia to ScreenerHero?
Yes. Translate your Stockopedia criteria into raw filters: P/E, ROE, EV/EBITDA, debt/equity and dividend yield carry over directly. The gap is StockRanks itself: ScreenerHero has a Piotroski F-Score and a formula-based Moat Score, but no composite rank that blends quality, value and momentum.
How does Stockopedia compare to Simply Wall St?
Both turn fundamentals into a composite output, for different jobs. Stockopedia is built for screening and ranking a whole market; Simply Wall St is built for discovering and monitoring individual companies.
US, Canada, Europe & Australia. One payment.
Filter by P/E, ROE, EV/EBITDA, and 40+ more metrics across US, Canadian, European & Australian equities — including microcaps. Free core screener, no account needed. Lifetime access is a one-time 97€ payment — no subscription.